William Blair downgraded AMN Healthcare (AMN) to Market Perform from Outperform without a price target following the Q3 report. The firm sees “simultaneous headwinds” across multiple businesses despite travel demand stabilization.
William Blair downgraded AMN Healthcare (AMN) to Market Perform from Outperform without a price target following the Q3 report. The firm sees “simultaneous headwinds” across multiple businesses despite travel demand stabilization.